Radiant Innovation Inc. (TPEX:3373)
17.95
+0.05 (0.28%)
Dec 29, 2025, 1:30 PM CST
Radiant Innovation Revenue
Radiant Innovation had revenue of 101.27M TWD in the quarter ending September 30, 2025, a decrease of -5.27%. This brings the company's revenue in the last twelve months to 413.06M, up 2.18% year-over-year. In the year 2024, Radiant Innovation had annual revenue of 420.53M with 0.49% growth.
Revenue (ttm)
413.06M
Revenue Growth
+2.18%
P/S Ratio
2.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
852.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 420.53M | 2.03M | 0.49% |
| Dec 31, 2023 | 418.50M | -146.06M | -25.87% |
| Dec 31, 2022 | 564.56M | -420.49M | -42.69% |
| Dec 31, 2021 | 985.04M | -1.63B | -62.36% |
| Dec 31, 2020 | 2.62B | 1.83B | 233.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |